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The purpose of this thesis was to investigate the in vitro effects of resveratrol on the sperm 
cell motility and viability. In order to do this, resveratrol was encapsulated in liposomal 
formulations in collaboration with the Department of Pharmacy, UiT-The Arctic University of 
Norway. Semen samples were obtained from the IVF clinic, University Hospital of Northern 
Norway (UNN). Current work was approved by regional ethic committee (REK), REK-
2014/032 REK Nord. 
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resveratrol for this thesis by your established method. Resveratrol incorporated in liposomes 
and liposomes without any additional substance (empty liposomes) were prepared. I did not 
personally prepare the resveratrol formulation of the liposomes used in this thesis, due to the 
time limitation. However, I observed some of the experiments preparing curcumin liposomal 
formulation at the Department of Pharmacy, UiT, for two days in April. I would therefore like 
to thank PhD student Selenia Ternullo and master student Laura Schulte, for spending time 
with me in order for me to understand with such techniques.  
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of our findings are also enhanced. The learning curve has been steep. Even though it has been 
many intensive weeks in the lab, many hours of microscopy from the beginning of April to 
the middle of May (sometimes even weekends and holidays), I will be forever grateful for 
everything I have learned during this amazing journey! I have a gotten a much deeper 
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Background: Resveratrol is found to have antioxidative properties and is reported as a 
protective pharmacological agent against several diseases. It is however a lipophilic and 
unstable substance because of its photosensitivity. In order to enhance the drug stability, 
solubility and to deliver the drug in the targeted area, it can be incorporated in a nano-sized 
vesicle of liposome formulations. The aim of this study was to identify whether the 
antioxidants such as resveratrol liposomal formulation has some in vitro effects on the 
motility and viability in human spermatozoa. Well known antioxidants such as vitamin C and 
vitamin E, were also included for comparison.  
 
Materials and methods: The liposomal formulation of resveratrol was prepared in 
collaboration with the Department of Pharmacy. Four drug samples, resveratrol-loaded 
liposomes, empty liposomes, vitamin C and vitamin E were used at three concentrations (1, 
10, and 100 µg/mL). Seventeen semen samples obtained from the IVF clinic, University 
Hospital of Northern Norway (UNN) were studied. After purification of the semen samples, 
sperm cells were treated with specified drug concentration in a 96 well plate. The motility of 
the sperm cells was observed with the microscope after 24 and 48 hours incubation at 5% CO2 
and 37 °C. The current work was approved by regional ethic committee (REK), REK-
2014/032 REK Nord.  
 
Results: Among more than 90% motile spermatozoa immediately after purification decreased 
to 35.5% after 24 hours under the normal in vitro conditions. Sperm cells containing 
antioxidants were found to be significantly less motile and significantly more immotile as 
compared to controls. No significant differences were seen between empty liposomes and 
control groups. After 48 hours of incubation, in the control group, 9.3% of spermatozoa were 
motile. Sperm cells containing the drug samples (empty liposomes, resveratrol, vitamin C and 
vitamin E) were significantly less motile and significantly more immotile especially at the 
highest concentration (100 µg/mL) as compared to the control.  
 
Conclusion: The direct antioxidant treatment on sperm cells did not improve the motility or 
viability of spermatozoa in vitro. Although we did not study the use of antioxidants for the 
IVF outcome, the use of such antioxidant substances in the semen sample purification media 
should be avoided in the IVF procedure. 
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1. Introduction  
 
Infertility is a disease of the reproductive system defined by the failure to achieve a clinical 
pregnancy after 12 months or more of regular unprotected sexual intercourse in a couple with 
reproductive age (1). Infertility affects approximately 15% of couple worldwide (2). Male 
factors contribute 20-30%, while female factors are responsible for 50% of causes of infertility. 
The remaining 20-30% are due to the combination of both male and female factors (3, 4). Male 
factor infertility affects approximately 7% of the general male population. For men, semen 
quality has been considered as one of the main factors in infertility (4).  
 
1.1. Current trends on semen quality  
 
Semen quality has been considered as one of the major parameters in men´s reproductive health. 
Generally, semen quality is examined by observing the seminal fluid volume, seminal fluid 
viscosity, sperm cell concentration or total sperm cell counts in the ejaculation, morphology 
and motility of sperm cells (5). According to WHO guidelines, for the semen quality to be the 
normal, there should be more than 1.5 mL seminal fluid volume, more than 15 million sperm 
cells/mL or more than 39 million sperm cells/ejaculate, more than 40% motile spermatozoa and 
more than 4% spermatozoa with normal morphology (5).  
 
Several studies have shown that the semen quality among men has been declining worldwide. 
Carlsen et al. published a meta-analysis in 1992, comparing semen quality data published from 
all six continents in the time period of 50 years (from 1938 to 1991). The results indicated a 
significant decline in seminal fluid volume and sperm cells concentration. Total sperm cell 
count during the past 50 years has been decreased to half (6).  
 
There are also regional differences in semen quality in men among the Scandinavian countries. 
Danish and Norwegian men have shown to have significantly poorer semen counts compared 
to Finish men (7-9). The study on the 20 year period (1993-2012) archival data of 5739 north 
Norwegian men showed that the semen quality of men among couples seeking infertility 




1.2. Cause of declining semen quality 
 
It is difficult to point out the only one cause for declining semen quality. There are reports 
suggesting that some factors such as increasing heat around testicles, working in the area of 
high intensity of radio frequency, keeping mobile phone in the pocket close to testicles and 
using laptops close to testicles, are among the physical causes of declining semen quality (11-
14). In addition, pollution and unhealthy food habits are also considered for the causes of 
declining semen quality (15, 16). One of the widely discussed research topic pointing as the 
causes of declining semen quality is the oxidative stress (3).  
 
1.3. Oxidative stress  
 
Oxidative stress is caused by the uncontrolled and overproduction of reactive oxygen species 
(ROS). Reactive oxygen species (ROS), also called oxygen free radicals, contain one or more 
unpaired electrons and therefore they are highly reactive oxidizing agents. They are formed as 
by-products during enzymatic reactions with oxygen during normal cellular metabolism (3, 17). 
Like all living cells under aerobic conditions, spermatozoa also face oxygen (O2) and therefore 
produce ROS during their normal metabolism (18). Free radicals “steal” electrons from 
surrounding structures, thereby causing disruption in neighboring structures as well as making 
other molecules to become subsequent free radicals (19). Examples of highly reactive ROS are 
the superoxide anion radical (O2 ), the hydroxyl radical (OH), the peroxyl radical (ROO) and a 
subclass of free radicals derived from nitrogen (e.g. nitric oxide (NO), peroxynitrate (ONOO-) 
(17, 20). Normally there is balance between oxidants and antioxidant systems to protect human 
cells against potential damage by ROS. When the production of ROS overwhelms the biological 
antioxidant defenses, a condition called oxidative stress occurs. This can lead to partly or fully 
cellular physiology destruction (21).  
 
Sperm cells contain only minimal amount of enzymes and antioxidant systems because of their 
significant lack of cytoplasm, the majority of antioxidants are contained in the seminal fluid 
(22). This includes enzymes such as superoxide dismutase (SOD) and catalase as well as non-
enzymatic substances like ascorbic acid (vitamin C), a-tocopherol (vitamin E), vitamin A 
(retionoid), urate, albumin among others (23). Leucocytes and immature spermatozoa have 
been shown to be the two main sources of ROS in man´s ejaculate (23, 24). However, a variety 
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of other factors enhance the oxidative stress, such as cigarette smoking, toxins, life style factors 
or conditions such as varicocele (3, 21).  
 
Oxidative stress can damage variety of the components and functions of the sperm cell. It can 
cause severe damages to plasma membrane and DNA, and also induce apoptosis (3). The 
plasma membrane of spermatozoa is particularly vulnerable, because of its high content of 
polyunsaturated fatty acids, and hence double bonds (25). This can affect semen parameters 
such as concentration, motility, morphology and therefore fertilization (3, 23). Although 
excessive concentrations of ROS cause sperm pathology, low and controlled (physiological 
levels) are believed to be important in important processes in normal sperm physiology and 
fertilization (3).   
 
1.4. Antioxidants and semen quality  
 
Oxidative stress has become an important target in the therapy of men´s reproductive health. 
Modification of lifestyle behaviors such as smoking, diet, alcohol use, obesity or psychological 
stress have been proposed together with the antioxidant supplement. Antioxidants are helpful 
in reducing the ROS activity (21, 22). Dietary antioxidants are obtained through oral intake of 
food (e.g. fruits, nuts, vegetable) or supplements (e.g. supplemental vitamins, minerals) (26). 
The role of antioxidants and their significance to semen quality, have also been investigated 
and debated in several studies. Therefore, antioxidants supplement, diet and lifestyle 
modifications have been considered to be the important factors to improve the semen quality 
(22, 27).  One of the small but interesting antioxidant molecules, resveratrol among other 
substances might be useful for therapeutic application however it has not been studied so far in 
my knowledge.  
 
1.5. Resveratrol  
 
Resveratrol, also known as 3,5,4-trihydroxystilbene and is characterized as a polyphenol. It is 
a compound that occurs naturally in some plants, including grapes, blueberry, groundnuts and 
pines. Red wine is one of the widely consumed dietary sources of resveratrol. It is produced by 
plants in response to pathogenic infection. And it is believed to exhibit fungicidal, antimicrobial 
and antiviral activities (28). Resveratrol is found to have antioxidative properties and protective 
against ROS (29). It also can prevent and slow progression of several chronic diseases, 
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including cancer, cardiovascular diseases and neurodegenerative diseases among others 
because of its antioxidant properties (30). Chemical structure of resveratrol together with other 
well known antioxidants such as vitamin C and vitamin E are shown in fig 1.  
 
Although, resveratrol is a potential multi-targeted antioxidant, it is a less stable lipophilic 
substance. Therefore, to obtain its optimal therapeutic effects, a novel and nano-formulation is 
necessary. For the current targeted aims, preparation and development of a liposomal 




Liposomes are small nano-size vesicles with spherical shape consisting of one or more 
concentric lipid bilayers enclosing a discrete aqueous space. They are usually prepared from 
phospholipids (31). Phospholipids can generally form closed structures when they are hydrated 
in water, because of their amphipatic nature, that is, having both hydrophilic and hydrophobic 
structures. When lipids are exposed to water, they arrange themselves exposing their polar 
(hydrophilic) head groups toward the water phase, while the apolar (hydrophobic) part stick 
together in the bilayer – thus forming closed concentric bimolecular lipid leaflets separated by 
aqueous compartments (32). The vesicle consists of simple lipid bilayers that resemble 
biological membranes, in the form of a spherical shell (33) as shown in Fig 2. 
 
Liposomal formulations can be characterized by properties such as particle size, charge, number 
of lamella, lipid composition as well as surface modification with polymers and ligands (31). 
The choice of bilayer components determines the rigidity or fluidity and the charge of the 
bilayer. Lipids composed of unsaturated phosphatidylcholine gives much more permeable and 
less stable bilayers, compared to saturated phospholipids that form rigid and less permeable 
barrier. The size of liposomes range very small (25 nm) to large (over 1000 nm) vesicles and 
they may also have one or bilayer membranes. Based on the number of bilayer, they are 
classified into multilamellar or unilamellar vesicles (32). Therefore, the type of lipid can control 
the liposome function in the drug delivery system.  
 
Because of their entrapping ability, liposomes are considered as drug-carrying structures of 
vesicles (33). The unique structure of liposomes, with both hydrophilic and hydrophobic parts, 
makes it possible to entrap different types of drugs. Hydrophilic drugs can be entrapped in the 
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aqueous interior. Lipophilic drugs can be incorporated in the hydrophobic core of the 
phospholipid bilayer as shown in fig. 2. Liposomal drug formulations mainly enhance the drug 
stability and solubility. Moreover, it can deliver the drug in the targeted area and time (31, 32).  
 
2. Aim of the thesis  
 
The direct effect of resveratrol on the sperm cell motility and viability has not been reported so 
far. In IVF clinics, semen sample has to be taken out of the body and exposed to the atmospheric 
oxygen during the process of purification. The in vitro oxidative stress might have effects on 
the sperm cell functions during IVF treatment. Therefore, it important to know whether 
antioxidants such as resveratrol might have effect on sperm cell motility and viability. The 
outcome of IVF treatment can be improved by using supplement of resveratrol in the medium 
or oral treatment to the patient for the improvement of semen quality if it is showing 
pharmacological effects.  
 
In order to achieve  the goal, it is aimed for a simple and preliminary screening test. Liposomal 
formulation of resveratrol is prepared and standardized. Semen samples from men were 
obtained from IVF clinic and purified by the standard methods. Different concentrations of 
resveratrol together with the liposomes were treated with the defined amounts of sperm cells 
and its effects on motility and viability were observed directly under microspore by the standard 














3. Materials and methods  
 
3.1. Chemicals / media  
 
Following chemicals and media were used in the experiment: Methylene blue hydrate (Sima-
Aldrich, Steinheim, Germany); Quinn’s AdvantageTM Fertilization (HTF) (SAGE In-Vitro 
Fertilization); Human serum albumin (Inc. a Cooper Surgical Company, Trumbull, USA); 
Quinn’s ® Sperm Washing Medium (SAGE In-Vitro Fertilization, Inc., Trumbull, USA); 
Spermgrad lower layer and Spermgrad upper layer (Vitrolife, Sweden). Lipoid S100 
Phosphatidylcholine (> 94% purity) from soybean, Lipoid GmbH, Ludwigshafen, Germany. 
Resveratrol ( ≥99 %, powder), Sigma-Aldrich Chemie GmbH, Steinheim, Germany 
 
3.2. Materials and equipment 
 
Following materials and equipments were used: Eppendorf tubes; Heraeus Sepatech; 
Neubauer improved, Tiefe Depth Profondeur 0,100mm (Superior, Marienfeld, Germany); 
Falcon 96-Well Cell Tissue Culture Plates (Corning Incorpotated, Corning, New York, USA); 
Falcon serological pipet 5 mL; Finnpipette: 0.2-2 µL, 2-20 µL, 20-200 µL, 100-1000 µL 
(Termo Fisher Scientific, Waltham, Massachussetts, USA); Büchi Rotavapor R-124 with 
Büchi Vac C-500 Vacuum Pump System, Büch Vacuum Controller B-721 and Büchi Water 
bath B-480 (Büchi Laboratechnik, Flaxil, Switzerland); Eppendorf Centrifuge; Forma 
Scientific, CO2 water jacked incubator; Megafuge 1.0, NICOMP Submicron Particle Sizer 
Model 370, Santa Barbara, California, USA; Zeiss Standard Binocular Microscope, Carl 
Zeiss, Oberkochen, Germany; Zetasizer Nanno-ZS, Malvern Instruments Ltd., Malvern, UK 
 
3.3. Collection of semen sample 
 
Semen samples were collected from men who came for their routine treatment in the IVF clinic, 
University Hospital of Northern Norway (UNN). The current work was approved by regional 
ethic committee (REK), regulations were strictly followed (REK-2014/032 REK Nord). All 
patients were informed of the purpose of donating their semen samples and signed a consent 
form (appendix 1).  
 
Semen samples were collected from the IVF clinic at University Hospital of Northern Norway 
(UNN). Samples were delivered to the clinic within one hour after ejaculation. The patients 
were instructed to be sexually abstinent for minimum 2-5 days before delivering the sample. 
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All patients received these guidelines before delivering the sample (appendix 2). Semen quality 
was assessed by the IVF lab initially using a standard protocol. The following semen parameters 
were assessed: 
• Seminal fluid volume (mL) 
• Sperm cell concentration (millions sperm cells/mL)  
• Total motility (%) 
• Motility grade (1-4)  
• Viscosity grade (1-3) 
 
All semen samples were analyzed in the IVF lab as routine clinical test. Only samples having 
normal semen parameters according to the WHO-criteria (5) were used in this thesis: 
• Seminal fluid volume: more than 1.5 mL 
• Total sperm cells number: more than 39 millions sperm cells per ejaculate  
• Sperm cells concentration: more than 15 millions sperm cells per mL 
• Total motility: more than 40% 
• Progressive motility: more than 32% 
  
A total of 17 semen samples from different men were studied in this thesis. 
 
3.4. Preparation of semen samples  
 
The seminal fluid contains many debris, non-germ cells, dead spermatozoa, among others in 
addition to normal spermatozoa. It is important to separate spermatozoa from seminal fluid 
within one hour after ejaculation as products from non-sperm cells can potentially damage the 
spermatozoa. Purification of semen sample is done by the standard clinical practice in IVF 
clinic (5).  
 
The two most common techniques used to yield a final preparation containing a high percentage 
of morphologically normal and motile cells are: 1) the density gradient centrifugation method 






3.4.1. Density gradient centrifugation method  
 
This method was carried out according to a protocol by the IVF clinic. The semen sample were 
collected in a falcon specimen container and delivered to the IVF clinic within 30 minutes after 
ejaculation. At the lab the container was stirred using a Stuart tiling-machine, 20-25 tilts per 
minute for 10 minutes in order to liquefy the samples. Thereafter the sample volume, the 
motility-grade of the spermatozoa, viscosity and total number of spermatozoa were estimated. 
Standardized WHO-criteria was used as references (5).  
 
For the purification of semen sample, two different gradients (spermgrad lower layer  and 
spermgrad upper layer) were used. Upper layer (1.5 mL) was pipetted on top of lower layer (1.5 
mL) into a Nunc-tube (10 mL). In order to have two district layers, this had to be done slowly 
and carefully. Semen sample (1.5 mL) was pipetted on top of these two layers carefully, in 
order to keep the layers separated. The tube was centrifuged at 500 x g for 20 minutes.  
 
After centrifugation the two top layers were removed. Most of the healthy sperm cells were 
collected at the bottom. The sperm cells (approx. 1 mL) containing layer on the bottom of the 
Nunc-tube was mixed with pre warmed Quinn’s sperm washing medium (5 mL). The tube was 
centrifuged at 300 x g for 10 minutes. After centrifugation, the supernatant was removed, 
leaving the pellet of sperm cells in the bottom of Nunc-tube. The same washing-procedure was 
repeated once more with washing medium (5 mL) thereafter centrifugation at 300 x g for 10 
minutes supernatant was carefully removed. After the second washing procedure, a Nunc-tube 
with a pellet of sperm cells was left. Then Quinn’s Advantage Fertilization medium containing 
human tubal fluid (0.5 - 1 mL) was added and mixed carefully. After this procedure, motility-
grade of spermatozoa, total number, concentration was assed once more. The prepared sample 
was kept into a CO2-incubator at 37 °C until clinical procedures were performed. After the 
clinical use, the remaining sample was used in the experiment.  
 
3.4.2. Direct swim up method  
 
This method is based on the facts that spermatozoa can be selected by their ability to swim out 
of seminal plasma into the culture medium (5).  
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The semen sample was transferred into a 10 mL centrifuging tube and diluted with 5 mL 
Quinn’s sperm washing media, and thereafter centrifuged at 700 x g for 10 minutes. After 
centrifugation, spermatozoa and other cells were collected at the bottom of the tube formed in 
a pellet with overlying supernatant containing semen plasma. Supernatant was removed as far 
down to the pellet as possible by pipetting. Thereafter Quinn’s sperm washing media (5 mL) 
was added to the centrifuging tube once more, and centrifuged at 700 x g for 5 min. The 
supernatant was once more removed. Thereafter the 1 mL of Quinn’s Advantage Fertilization 
(HTF) media was added to the pellet. This was done as gently as possible, in order to prevent 
mixing of the pellet. The tube was put in a CO2 incubator for one hour. After one hour there 
was formation of a motile spermatozoa containing turbid cloudy area in the middle of the layer, 
some millimeters above the pellet. This cloudy portion, containing high concentration of 
spermatozoa, was transfered into another test tube. Immotile sperm cells and other cells such 
as leucocytes were left as pellet. Motile sperms were used in the experiments. 
 
3.5. Preparation of liposomes 
 
Lipid (SPC-100) was weighed (200 mg) and transferred into a round bottom flask (100 mL), 
thereafter 10 mg of resveratrol was added into it. Methanol (approx. 20 mL) was added into 
round bottom flask in order to dissolve lipid and resveratrol together. The flask was stirred by 
hand, until all the substances were dissolved.  
 
In order for the methanol to evaporate, a rotatory evaporator (rotavapor), Büchi Rotavapor R-
124 with Büchi Vac V-500 Vacuum Pump System, Büchi Vacuum Controller B-721 and Büchi 
Water Bath B-480, were used. The flask rotated for one hour with optimally adjusted pressure 
and temperature. All methanol was evaporated during one hour leaving behind a very thin and 
uniform film of lipid layer together with the resveratrol on the walls of the flask. In order to 
hydrate this lipid layer, a buffer (10 mL) was added to this mixture. It was shaken by hand in 
order to form vesicles. Thus formed  liposomes were stored in the refrigerator for a minimum 
24 hours before further preparation. Both resveratrol incorporated in liposomes and liposomes 





3.5.1. Extrusion of liposomes and size reduction 
 
We were expecting that a uniform liposome size of approximate 100 nm would be up taken 
by the sperm cells. Size reduction was carried out by the extrusion method. Both resveratrol 
liposomes and empty liposomes were stored for at least 12 hours in the refrigerator. Before 
extrusion the liposomes were kept on the bench for one hour to bring at room temperature. 
For the extrusion, 800 nm filter pore size of Nuclepore® polycarbonate membranes 
(Whatman International Ltd., UK) were used. By using membranes pores size of 400 nm and 
200 nm the liposomes size was further reduced. Subsequently the liposomal dispersion 
(approx. 10 mL) was further extruded using the membrane sizes 100 nm. Extrusion through 
membrane was repeated five times through each membrane in order to obtain a homogenous 
size distribution. After finishing the extrusion, the liposomes were stored in the refrigerator at 
4 °C until their use. 
 
3.5.2. Characterization of liposomes 
 
The sample was prepared in a laminar airflow bench to avoid dust contamination. NICOMP 
Submicron Particle Sizer Model 370 with a Helium-Neon diode laser operating at 632.8 nm 
(NICOMP, USA) was used to measure the particle size. Glass test tubes were filled with 
distilled water and then sonicated in an ultrasonic bath for 15 min. At first the sonicated tubes 
were rinsed three times with filtered distilled water (Bulk Acrodisc® syringe filter with a 0.2 
µm Supor® Membrane, PALL Life Sciences, Fribourg, Switzerland) and then the dispersion 
was diluted to an intensity of 250-350 kHz (34). The measurement settings were adjusted to 
current conditions such as temperature, the resulting viscosity of water and the incident angle 
was set to 90°. Each sample was measured 3 times for 10 min. The results are presented as 
intensity weighted distributions. Resveratrol entrapment efficiency was more than 80%.  
 
3.6. Preparation of drug samples  
 
In this study, the following drug samples were used: empty liposomes (liposomes without 
resveratrol), resveratrol incorporated in liposomes, vitamin C, and vitamin E (soluble form). 
All four drug samples were diluted to three different concentrations with Quinn’s advantage 
fertilization medium in order to form 100 µg/mL (A), 10 µg/mL (B) and 1 µg/mL (C) as the 
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final concentrations to sperm cells treatment. Sperm cells containing Quinn’s advantage 
fertilization medium only was used as control.  
 
Vitamin C and vitamin E were prepared to an initial stock solution concentration of 10 mg/mL, 
while resveratrol incorporated in liposomes and liposomes only had an initial concentration of 
lipid as 20 mg/mL. In order to get concentration A (100 µg/mL), the vitamin C and E were 10 
times diluted with Quinn’s advantage fertilization media by mixing stock solution of vitamin C 
or vitamin E (50 µL) with 450 µL of Quinn’s advantage fertilization media, then mixed 
thoroughly by vortex shaking for approximately 5 seconds. Resveratrol incorporated in 
liposomes and liposome only was diluted 20 times i.e. of empty liposomes or resveratrol 
incorporated in liposomes (25 µL) was diluted with 475 µL of Quinn’s advantage fertilization 
media, respectively in order to obtain concentration A.  
  
In order to get concentration B (final concentration as 10 µg/mL to the sperm cells), sample A 
was diluted 10 times. For this, of sample A (50 µL) was diluted to 500 µL with Quinn’s 
advantage fertilization media, from each drug sample. By the similar way, in order to get sample 
C (final concentration 1 µg/mL to the sperm cells), sample B was diluted 10 times (50 µL of 
sample B + 450 µL of Quinn’s advantage fertilization media). Resveratrol-lipid ratio in the final 
concentration was 0.8:20.  
 
The samples were stored in the fridge when not in use. However, they were kept at room 
temperature for minimum one hour before using the samples for the experiments. Each set of 
drug samples were used for five semen samples, thereafter a set of fresh drugs samples were 
prepared from the stock solutions.  
 
3.7. Preparation of sperm cells  
 
Cell counting is one of the important steps for this experiment. Cell counting is followed as 
described in WHO manual (5). In brief, the purified semen samples were diluted with 
methylene blue solution as 10 or 20 times depending on the initially estimated number of 
spermatozoa in the sample. Semen samples containing more than 20 million/mL were diluted 
20 times by mixing  50 µL of purified semen sample with 950 µL of methylene blue. Samples 
containing less than 20 million/mL sperm cells concentration were diluted 10 times by mixing 
50 µL of semen sample with 450 µL of methylene blue. Semen samples were thoroughly 
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mixed and left on the bench for 10 minutes to stain properly. Thereafter, it was transferred to 
a improved Neubauer heamocytometer with covering slit, on both sides of the 
haemocytometer. This was kept into a humid chamber for 10 minutes, in order for the 
spermatozoa to sediment and be properly visualized under the light microscope. 
 
There were 25 big squares in the middle part of improved Neubauer haemocytometer, each of 
these had 16 smaller squares. Depending on the number of spermatozoa in one big square, we 
determined how many big squares that were needed to count.  
• <10 spermatozoa in one big square, all 25 big squares were counted  
• 10-40 spermatozoa in one big square, 10 big squares were counted 
• >40 spermatozoa in one big square, 5 big squares were counted  
 
In average, to calculate the sperm cell concentration approximately 200 cells were counted. 
Counting was done on both sides of the hemocytometer, in order to check if the number were 
close. The sperm cells counted in 25 large square was taken as number of sperm cells per 100 
nL. Based on the dilution factor, the concentration in the original purified sample were 
calculated by multiplying by the dilution factor.  
 
3.8. Dilution of purified semen samples 
 
Every semen sample was diluted to having a sperm cell concentration of 250 000 cells per mL 
with the fertilization media in order to have approximately 100 spermatozoa per vision filed 
under the microscope with 200 times expansion. This number was based on laboratory exercises 
and preparations before starting the thesis work. For our experiments, it was aimed at having 3 
mL of diluted purified semen sample with the concentration of  250 000 cells per mL in order 
to have enough volume (90 µL*26 = 2340 µL).  
Diluted purified semen sample (90 µL each) was transferred into each of the middle portion 26 
wells in the Falcon 96-well plate, as shown in the figure 3. In five rows, which are as shown in 
the figure for control, liposomes only, resveratrol in liposomes, vitamin C and vitamin E. In 





3.9. Application of drug sample to Sperm cells 
 
After the drug samples and semen sample were prepared, as mentioned earlier four different 
drug samples, with three concentrations (A, B, C), each with 10 µL in volume, were added into 
90 µL of  semen samples. For control group, 10 µL media only was added into the semen 
sample. Therefore, we had the following samples prepare the following combinations:  
• Sperm cell + media only = control  
• Sperm cell + liposomes only (A, B and C) = sample 1 
• Sperm cell + resveratrol incorporated in liposomes (A, B and C) = sample 2   
• Sperm cell + vitamin C (A, B and C) (positive control) = sample 3  
• Sperm cell + vitamin E (A, B and C) (positive control) = sample 4  
 
Each set of experiment was duplicated, in order to minimize the risk of experimental errors. 
Therefore, a total of 26 wells were used as shown in figure 3. 
 
Each time we aimed of using the same amount and concentration of sperm cells, in order to get 
uniform results. Each of the plates were incubated at 37 °C and 5% CO2 for 24 hours before 
motility and viability was assessed under the microscope.  
 
 
3.10. Observation of sperm cell viability and motility 
 
The plates were examined for sperm cell motility and viability after approximately 24 and 48 
hours of drug treatment and incubation. The spermatozoa motility and viability was assessed 
under the light microscope according to guidelines in the WHO lab manual for examining and 
processing human semen (5). The motility of spermatozoa can be divided into three different 
categories: 
• Progressive motility (PR): Spermatozoa moves actively, either linearly or in a large 
circle, regardless of speed.  
• Non-progressive motility (NP): All patterns of motility with an absence of 
progression, e.g. swimming in small circles, the tail force hardly displacing the head, 
or when a tail beat can be observed.  
• Immotility (IM): No movement.  
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All 26 wells were counted in microscope after 24 hours and 48 hours of incubation. The 
spermatozoa were observed under an inverted microscope. They were examined with an 
objective 20 x. When looking into the lens, there was a marked rectangular area in the eyepiece 
field area, as shown in fig. 4. Only spermatozoa inside this area, were counted. Approximately 
a total between 60 and 120 sperm cells in each field area were counted, with the number of 
progressive, non-progressive and immotile cells assessed. Two randomly chosen regions were 
counted in each well. Regions close to the rim of the wells were excluded. In total of 17 semen 
samples from different patients were studied.  
 
3.11. Statistical methods  
 
The results from microscopic observations were transferred into Microsoft Excel, version 
2018 (Microsoft Corporation, Redmount, Washington, USA). The data were categorized 
according type of sample used, time of observation (24 or 48 hours) and classified as motile 
or immotile. The statistics were calculated using Excel. The means of motile and immotile as 
well as percentage, was calculated for each patient sample. When all samples were calculated 
the mean of the percentages from each category for each patient sample were calculated. Each 
data was the average of four point observations. The results are expressed as mean ± SD 
(standard deviation) and n =17. 
 
For the statistically difference a two-tailed student t-test was performed to compare the 













4. Results      
 
4.1. Baseline data  
 
The data in this thesis were collected between 21st March  to 16th May in 2018. Semen 
samples were obtained from the IVF clinic, UNN. All patients had signed a consent form in 
advance. Only semen samples having normal semen quality according to the WHO criteria 
were included (5). 
 
In total, the results of 17 semen samples were included in this thesis. Ten samples were 
purified by the IVF clinic using the gradient separation method, while 7 samples were 
purified in the IKM-lab by using the swim-up method. Table 1 shows the mean age and 
general semen characteristics as well as standard deviation of the patients included in this 
thesis. The youngest patient was 29 years and the oldest 42 years.  
 
In this thesis we tested in vitro how motility and viability of sperm cells were affected by the 
direct treatment resveratrol, vitamin C and vitamin E at 100 µg/mL (A), 10 µg/mL (B) and 1 
µg/mL (C) concentrations. Resveratrol, a poorly soluble in water, is an unstable substance 
because of its photosensitivity (28). Resveratrol was therefore encapsulated in liposomes. 
Empty liposomes were also used as an additional substance to see whether lipid itself has 
some effects. The liposomal formulations were prepared in collaboration with the Department 
of Pharmacy, UiT. Therefore, there were four different samples such as empty liposomes, 
resveratrol encapsulated liposomes, vitamin C and vitamin E at three different concentrations; 
100 µg/mL (A), 10 µg/mL (B) and 1 µg/mL (C). Media only treated group was used as 
control. For all dilution of drug samples and semen samples the same Quinn’s advantage 










4.2. Effects of empty liposomes, resveratrol, vitamin C and vitamin E on sperm cell 
motility and viability 
 
Generally, over 90% sperm cells are motile after purification in a normal sample. We 
observed the motility of spermatozoa after 24 hours. Among the controls, only 35.5% of the 
spermatozoa were found to be motile. The effects of empty liposomes, resveratrol liposomes, 
vitamin C and vitamin E on sperm cell motility after 24 hours treatment as comparing to 
control, are shown in Table 2. There is no significant difference in motility with the addition 
of empty liposomes compared to controls, however motility is slightly decreased. 
Spermatozoa exposed to antioxidants are significantly less motile than normal spermatozoa at 
all concentrations. Samples with encapsulated resveratrol are significantly less motile 
compared to control at all concentrations, the motility decreases as the concentrations gets 
higher. Both vitamin E, vitamin C and resveratrol makes the spermatozoa significantly less 
motile at 100 µg/mL, however vitamin C is found to most effective to reduce the sperm cell 
motility as only 10.2% of spermatozoa are motile, compared to 25.7% with resveratrol and 
26.3% with vitamin E, respectively.  
 
 
Generally, less than 10% of normal sperm cells are found immotile after immediate 
purification. We observed that the percentage of immotile sperm cells had increased up to 
64.5% in in vitro condition after 24 hours. The results in Table 3 shows the effects of empty 
liposomes, resveratrol, vitamin C and vitamin E on sperm cell immotility after 24 hours of 
treatment at 37°C and 5% CO2. There is no significant difference in sperm cell immotility 
between controls and empty liposomes groups. Semen samples containing the antioxidants 
had significantly increased the percentage of immotile sperm cell after 24 hours compared to 
controls. 89.8% of spermatozoa exposed to vitamin C at 100 µg/mL were significantly more 
immotile compared to control, a very high percentage comparing both resveratrol and vitamin 
E (74.3% and 73.7% respectively).  
 
It is observed that 9.3% of sperm cells were found motile under in vitro condition after 48 
hours. Table 4 shows the effects of empty liposomes, resveratrol, vitamin C and vitamin E at 
various concentrations on sperm cell motility after 48 hours of treatment. Sperm cells 
containing empty liposomes at 100 µg/mL are significantly less motile as compared to 
controls, however no differences are seen at 1 µg/mL and 10 µg/mL. Sperm cells on treating 
with resveratrol at 100 µg/mL are found significantly less motile compared to controls but no 
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significantly differences are seen at 1 and 10 µg/mL. Sperm cells on treating with vitamin C 
and vitamin E are significantly less motile at 100 µg/mL and 1 µg/mL compared to normal, 
however no difference is seen at 10 µg/mL.  
 
The percentage of immotile sperm cell increased up to 90.7% at in vitro condition after 48 
hours. The results in Table 5 shows the effects of empty liposomes, resveratrol, vitamin C and 
vitamin E on sperm cell immotility after 48 hours of incubation at 37°C and 5% CO2. Sperm 
cells containing empty liposomes at 100 µg/mL are significantly more immotile as compared 
to controls, no difference is seen at 1 and 10 µg/mL. Sperm cells with resveratrol at 100 
µg/mL significantly increased immotile cells compared to controls, no difference is seen at 1 
and 10 µg/mL. Sperm cells on treating with vitamin C and vitamin E significantly increased 
the percentage of immotile sperm cell at 100 µg/mL and 1µg/mL compared to normal, 
however no difference is seen at 10 µg/mL. 
5. Discussion  
 
We investigated the effects of various concentrations of liposomal formulations of resveratrol 
as well as vitamin C and vitamin E on sperm cell motility and viability after 24 hours and 48 
hours of treatment. Three different concentrations (1, 10, 100 µg/mL) were used in the 
preliminary screening. The spermatozoa were counted under the microscope as progressively 
motile (PR), non-progressive (NP) and immotile (IM) sperm cells. However, in order to make 
simple screening results the percentage of progressively motile (PR) and non-progressive 
motile (NP) sperm cell are expressed to total percentage of motile sperm cell. Indirectly, 
motile sperm cells are considered as viable sperm cells and immotile sperm cells are non-
viable sperm cells. No studies have reported so far on the potential influence of resveratrol on 
sperm cell motility and viability in vitro, therefore resveratrol was chosen for this study. We 
also selected well known antioxidants such as vitamin C and vitamin E for comparison.  
The current research project was designed as a simple screening tool to observe a direct in 
vitro effect of antioxidants like resveratrol, vitamin C and vitamin E on the sperm cell motility 
and viability. In the IVF clinic, sperm cells and egg cells are needed to culture in media, 
which include several supplements. It is not clear whether all supplements included in the 
different kinds of media are needed. Their consequences and effects on in vitro fertilization 
and embryo development still are not understood.   
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Resveratrol, vitamin C and vitamin E are well established antioxidants. The structures of 
these compounds are shown in figure 1. Vitamin C is a hydrophilic and vitamin E is a 
lipophilic antioxidant, and they have well defined bioavailability. Resveratrol however is 
lipophilic and poorly soluble in water. It is also a photosensitive and an unstable compound. 
Therefore a way of making it more soluble for reaching the drug target and increase the 
stability, a liposomes formulation was designed (28). A special nanoparticle-based 
formulation using liposomes is a way to deliver therapeutic agents. Liposomes have been 
extensively studied for their controlled and targeted drug delivery and are used in the 
treatment of various diseases (35).  
As expected, the motility of spermatozoa decreased after 24 hours of incubation, 35.5% of 
spermatozoa were found to be motile. The antioxidants such as resveratrol, vitamin C and 
vitamin E did not improve neither the semen motility or viability. After 24 hours of 
incubation, quite the reverse effect was seen. All semen samples containing the antioxidative 
substances (resveratrol, vitamin C and vitamin E), were significantly less motile and viable at 
all concentrations. No difference was seen between the empty liposomes and controls. 64.5% 
of the spermatozoa were immotile after 24 hours, the immotility in semen samples containing 
antioxidants, was significantly higher compared to normal. These effects were seen especially 
in vitamin C. At the higher concentrations, only 26.9 and 10.2% of spermatozoa containing 
vitamin C were motile at 10 and 100 µg/mL respectively (73.1 and 89.8% immotility).  
 
No improvement on motility was seen after 48 hours either, the differences were also less 
significant at this time. Both empty liposomes and the antioxidants caused a significant 
decrease in motility and viability, and therefore immotility, at the highest concentration, 100 
µg/mL respectively. Vitamin C and vitamin E, decreased motility and viability, and 
immotility at the lowest concentration, 1 µg/mL, after 48 hours respectively.  
 
As mentioned, there are no reports on sperm cell motility and viability concerning resveratrol 
in vitro. However, the effect of resveratrol on cryopreservation has been studied.  Marcia et. 
al. found resveratrol to be able to avoid oxidative damages to sperm in the cryopreservation 
process. Resveratrol was found to prevent damage to the lipid membrane of spermatozoa. 
However, it was not able to prevent loss of motility, which is observed after cryopreservation 
(36). In this thesis, resveratrol was not able to improve neither motility nor viability in vitro. 
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In our experiment, the application of antioxidants in vitro, caused significant decrease in both 
motility and viability in all semen samples at all concentrations after 24 hours. The 
differences were less prominent after 48 hours. Despite this, there are a number of reports 
showing dietary supplements and antioxidants can improve the semen quality. Mendiola et. 
al. found that men with normal semen parameters had significantly higher intake of 
carbohydrates, fiber, folate, vitamin C and lycopene compared to patients with normal semen 
parameters. The intake of protein and total fat was also found to be lower in men with normal 
semen quality (37). Eskenazi et. al. found positive associations between intake vitamin C, 
vitamin E and beta carotene concerning semen parameters. Men with high intake of these 
antioxidants had better sperm concentration, more progressively motile sperm compared to 
men with lower intake (38).   
 
Keskes-ammar et. al. examined the therapeutic effect of increased antioxidant intake on 
semen parameters in a prospective study. 54 men were randomized to treatment with vitamin 
E-selenium supplementation or vitamin B, lasting 3 months. Semen parameters were 
analyzed, as well as measurement of MDA-levels (lipid peroxidation marker) and levels of 
vitamins in serum. They found that patients receiving vitamin E combined with selenium had 
significantly decreased lipid peroxidation and improved semen motility after 3 months of 
supplementation. Patients receiving vitamin B didn’t have any effect (39). Wirletner et. al. 
investigated the influence of antioxidant on semen quality. Men were divided into two groups 
based on their semen quality that is, having oligoastenoteratozoospermia (OAT) or non-OAT 
(normal semen quality). Both groups received an antioxidant supplementation for two months 
(containing vitamin C, vitamin E, folic acid, zinc, selenium, N-acetyl-L-cysteine, L-carnitine, 
Citrulline, Glutathione red., Lycopene and Coenzyme Q10). They observed significantly more 
motile spermatozoa and the number of immotile cells had decreased significantly in the OAT-
group. There was also significantly higher number of total sperm, and the percentage of 
morphologically normal sperm cells was also increased this group. Non-OAT patients did not 
have significant changes in motility, total sperm cell number however (40).  
 
The results obtained by using antioxidants on in clinical trials as discussed above, cannot be 
directly compared to the results of ours. In contrast to the reports described above, we did not 
examine the dietary intake of antioxidants in this thesis, nor factors such as lifestyle, smoking, 
exercise or others. We examined the effect of direct application of antioxidants in 
spermatozoa in vitro. Based on the results we got, we cannot see any improvement in motility 
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or viability with the use of antioxidants. Wirletner et. al. also noted that antioxidants did not 
improve the semen quality on the normal patient (non-OAT) (40). We were also using only 
normal semen samples. As already mentioned, sperm cells on treating with antioxidants were 
less viable and motile, compared to controls. It appears that direct application of antioxidants 
has a toxic effect on sperm cells, especially effects of vitamin C. After 24 hours, only 10.2% 
of spermatozoa were motile at 100 µg/mL of vitamin C treatment, as compared to 35.5% of 
normal sperm cells (thus 89.8% immotility with vitamin C vs. 64.5% in controls). After 48 
hours of incubation, only 0.4% of spermatozoa were motile at 100 µg/ of vitamin C treatment, 
compared to 9.3% in controls (thus 99.6% immotility with vitamin C vs. 90.7% in controls).  
 
All semen samples were obtained from the IVF clinic. We aimed to include as many patients 
as possible in this thesis, however, only 17 patients could be eligible for the study during 
stated period of time. Ten of the semen samples were purified by the density gradient 
separation method, while the other 7 were purified in by the swim-up method. We are aware, 
that the samples should have been purified the same and uniform way. Generally, both 
methods are used in order to separate spermatozoa from seminal plasma and are well accepted 
in clinics. The swim-up method is often used in semen samples that are considered to be 
largely normal, whereas the gradient separation method is preferred in cases of severe 
oligozoospermia, teratozoospermia or asthenozoospermia. The two methods are somewhat 
different in the efficiency of getting the total number of motile spermatozoa, yielding 
morphologically normal spermatozoa and in producing different levels of contamination. 
Despite the differences in terms of efficiency reported, both methods are used to separate the 
spermatozoa from seminal plasma and yield the best spermatozoa from samples (5). The 
results in the two methods were not compared at this thesis. The use of two methods therefore 
constitutes a limitation. In addition, it is only a preliminary screening test and the effects of 











The antioxidants used in this thesis, did not improve the semen motility and viability. Rather 
the reverse effects were seen after 24 hours of treatment, as all spermatozoa containing 
antioxidative substances, at all concentrations, were less motile and viable. Lipid, 
phosphatidylcholine used to prepared liposomes, did not significantly change the sperm cell 
viability and motility as compared to controls. Vitamin C is found to be highly toxic 
comparing to resveratrol and vitamin E.  
 
It appears that the direct antioxidants application on sperm cells do not have any beneficial 
effects concerning motility and viability of spermatozoa in vitro. Therefore, using 
antioxidants on the media for the purification or culture of sperm cell or human embryo 
should be debated. This thesis is only a simple and preliminary screening tool. In order to 
clarify further, more semen samples should be examined, and more extensive investigations 
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8. Tables  
 
Table 1: Baseline data of age and semen parameter. 
Age and semen parameters  Mean and standard deviation 
Age (years) 35.6 ± 6.6 
Semen volume (mL)  3.1 ± 1.0 
Viscosity grade 2.4 ± 0.7 
Sperm cell concentration (millions/mL) 52.5 ± 19.6 
Motility (%) 59.1 ± 10.4 
Motility grade 2.6 ± 0.5 
Results are expressed as mean ± SD (n = 17). 
 
 
Table 2: Effects of empty liposomes, resveratrol-liposomes, vitamin C and vitamin E on in 




Total motile  
(PR + NP) % 
Control Media only 35.5 ± 11.0 
Empty liposomes 1 µg/mL (C) 31.7 ± 7.8 
 10 µg/mL (B)   33.5 ± 7.3 
  100 µg/mL (A) 33.7 ± 8.4 
Resveratrol 1 µg/mL (C) 31.0 ± 7.2 * 
 10 µg/mL (B)  29.0 ± 11.4 ** 
  100 µg/mL (A) 25.7 ± 11.8 ** 
Vitamin C 1 µg/mL (C) 29.2 ± 8.0 ** 
 10 µg/mL (B)  26.9 ± 8.0 ** 
  100 µg/mL (A) 10.2 ± 8.7 ** 
Vitamin E 1 µg/mL (C) 26.7 ± 11.6 * 
 10 µg/mL (B)  28.1 ± 9.1 * 
  100 µg/mL (A) 26.3 ± 8.1 ** 
 












Table 3: Effects of empty liposomes, resveratrol, vitamin C and vitamin E on in vitro sperm 
cells immotility after 24 hours in incubator at 37°C and 5% CO2. 
  
Media /drug 
concentration Immotile % 
Control Media only 64.5 ± 18.8 
Empty liposomes 1 µg/mL (C) 68.3 ± 20.5 
 10 µg/mL (B)   66.5 ± 20.6 
  100 µg/mL (A) 66.3 ± 21.5 
Resveratrol 1 µg/mL (C) 69.0 ± 20.6 * 
 10 µg/mL (B)  71.0 ± 26.6 ** 
  100 µg/mL (A) 74.3 ± 18.2 ** 
Vitamin C 1 µg/mL (C) 70.8 ± 16.3 ** 
 10 µg/mL (B)  73.1 ± 21.4 ** 
  100 µg/mL (A) 89.8 ± 17.8 ** 
Vitamin E 1 µg/mL (C)   73.3 ± 15.6 * 
 10 µg/mL (B)  71.9 ± 18.6 * 
  100 µg/mL (A) 73.7 ± 18.8 ** 
 
Results are expressed as mean ± SD (n = 17).  *P-value < 0.05, **P-value < 0.01 
 
 
Table 4: Effects of empty liposomes, resveratrol, vitamin C and vitamin E on in vitro sperm 




Total motile  
(PR + NP) % 
Control Media only 9.3 ± 7.4   
Empty liposomes 1 µg/mL (C) 7.9 ± 5.2   
 10 µg/mL (B)  9.4 ± 7.0 
  100 µg/mL (A) 5.2 ± 6.1 * 
Resveratrol 1 µg/mL (C) 7.2 ± 4.7 
  10 µg/mL (B)  6.3 ± 5.5  
  100 µg/mL (A) 3.3 ± 4.0 ** 
Vitamin C 1 µg/mL (C) 6.5 ± 4.4 * 
  10 µg/mL (B)  7.2 ± 4.6 
  100 µg/mL (A) 0.4 ± 0.9 ** 
Vitamin E 1 µg/mL (C) 5.8 ± 4.4 * 
 10 µg/mL (B)  8.1 ± 5.9 
  100 µg/mL (A) 5.2 ± 4.0 * 
 




Table 5: Effects of empty liposomes, resveratrol, vitamin C and vitamin E on in vitro sperm 
cells immotility after 48 hours in incubator at 37°C and 5% CO2. 
  
Media /drug 
concentration Immotile % 
Control Media only 90.7 ± 17.5 
Empty liposomes 1 µg/mL (C) 92.1 ± 16.3 
  10 µg/mL (B)   90.6 ± 21.9 
  100 µg/mL (A) 94.8 ± 23.0 * 
Resveratrol 1 µg/mL (C) 92.8 ± 19.4 
 10 µg/mL (B)  93.7 ± 23.2 
  100 µg/mL (A) 96.7 ± 19.0 ** 
Vitamin C 1 µg/mL (C)  93.5 ± 17.0 * 
 10 µg/mL (B)  92.8 ± 17.0 
  100 µg/mL (A) 99.6 ± 16.2 ** 
Vitamin E 1 µg/mL (C) 94.2 ± 18.8 * 
  10 µg/mL (B)  91.9 ± 16.9 
  100 µg/mL (A) 94.8 ± 10,3 * 
 



















9. Figures  
 
 
Figure 1: Chemical structures of antioxidants (resveratrol, vitamin C and vitamin E) used in 
the experiment (28).  
 
 
Figure 2: The schematic representation liposomes, and entrapment of lipophilic drug. The 
unstable and less soluble substance like resveratrol in the liposomal formulation can show its 
optimal pharmacological effects. Therefore resveratrol liposomal formulation was choosen in 
the current project. (This figure is taken from PhD Thesis of May Wenche Jøraholmen with 






































Figure 4: Observation field seen in the microscope where sperm cell viability and motility 
were observed. Photo: Stefan Thomassen
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10.Grade evaluations  
Reference: Keskes-Ammar L, Feki-Chakroun N, Rebai T, Sahnoun Z, Ghozzi H, Hammami S, et al. Sperm oxidative 




Recommendation                       B
Aim Materials and methods Results Discussion and comments
To evaluate the effects of 
vitamin E and selenium 
supplementation on lipid 
peroxidation and on 
sperm parameters.
Study design: RCT study. 
Study population: 
Targeted to 78 infertile men who came to clinic for 
the fertility treatment. 54 of them were recruited 
for open randomized control test over a period of 
10 month. Patients were randomly allocated to one 
of the two groups: Oral dose vitamin E and 
selenium (28 men) Oral dose vitamin B (26 men)
Composite vitamin B was used as control instead 
of placebo and was chosen on the basis of its usual 
prescription in some cases of infertility. Three 
months of treatment was chosen to allow for a full 
spermatogenesis cycle. At the end of the 
experiment, only 20 patients completed trial with 





Semen parameters such as, volume, concentration, 
motility, viability and morphology were 
determined on freshly ejaculated semen obtained 
after minimum 3 days of sexual abstinence.
Oxidative stress were evaluated by by measuring
lipid peroxidation markers, malondialdehyde 
(MDA) levels and body antioxidative status  were 
preformed by measurement of vitamin E and 
cholesterol levels. 
Statistical analysis:
• Chi-square test and the student t-test to 
compare statistical significance. 
• Regression equations and correlation factors 
were calculated using the least-squares method. 
• P-values <0.05 were considered as significant. 
There were no statistically significant between all parameters 
of the two initially treated groups of patients (vitamin E-
selenium and vitamin B) at the point of entry in the trial, 
MDA-concentration:
• In the initial treated group (N: 54), MDA-concentrations 
in sperm pellet suspensions were much less than that in 
seminal plasma. There was wide variability in semen 
MDA-concentration. 
• A positive correlation between MDA-concentrations in 
seminal plasma and in sperm pellet was found. 
• Motility and viability were highly and inversely correlated 
with semen MDA-level in the initial treated group of 
patients (N: 54). 
• MDA-levels were significantly higher in patients having 
semen anomalies compared with normospermic patients. 
• No correlation was seen between MDA-concentration and 
vitamin E/cholesterol ratio. 
Treatment of patients with vitamin E-selenium produced a 
significant increase in serum vitamin E levels and a 
significant decrease in semen MDA-concentrations. No 
significant effect on semen MDA-levels and serum vitamin E 
concentrations were seen after vitamin B supplementation.
Treatment with vitamin E-selenium induced improvement of 
sperm cell motility and concentration. There was an inverse 
significant correlation between semen MDA-concentration 
(in seminal plasma and in sperm pellet) and sperm motility 
and viability in patients treated with vitamin E-selenium. 
Was the objective of the study described clearly? Yes. 
Were the samples allocated to the defined groups with randomized procedure? Yes, 
with random numbers which was withheld from researchers and patients. 
Were all participants accounted for at the end of the study? No, 64% patients dropped 
out. 
Were the participants/study-person blinded in terms of group identification? Yes.
Were the groups equal at the start of the study? Yes, from what they measured. 
Were the groups treated equally? Yes, the oral drug administration in both groups. 
What are the results? Vitamin E-selenium treatment significantly lowered MDA-levels and 
improved sperm motility 
Can the results be transferred/used in clinical practice? Based on the having one study, 
we cannot state this clearly. However, to give vitamin E-selenium is a simple and 
practically possible – as well as measurement of MDA-levels.  
Were all the outcome validations assessed? Yes. 
Are the benefits worth the harm/costs? Unclear from the evidence as is stands today. 
Too little evidence.  
Strengths
• Only infertile men were included
• The treatments in the trial were randomized, both to patients and researchers and 
sufficiently described. 
• Long enough follow-up time.
• Refers to other studies, showing similar results.  
• The groups were comparable in terms of semen parameters and other parameters 
measured. 
• Exposures and and outcomes was measures the same way.
Limitations
• The trial was open.
• Diagnosed infertility was not a criteria for attending the study. 
• Few sample size. 
• Many patients dropped out of treatment.  
• Diagnosed infertility was not a selection criteria. Appears as all patients admitted for 
semen analysis in the particular clinic were recruited, inclusion/exclusion criteria are 
poorly described/not existing. 
• Drug compliance not assessed. 
• The person who evaluated the results (endpoints) was not blinded to the group 
identification.
Does the results have biological explanations? Yes
Does the author refer to other literature that supports or contradicts the results? Yes
Low quality randomized trial.
Conclusion
Oral treatment of 
unselected infertile men 
by vitamin E-selenium 
over period of 3 months 
significantly improved 
sperm cell motility and 
caused significant 












Reference: Wirleitner B, Vanderzwalmen P, Stecher A, Spitzer D, Schuff M, Schwerda D, et al. Dietary supplementation of antioxidants 





Aim Materials and methods Results Discussion and comments
Investigate the influence of oral 
antioxidative supplementation on 
sperm quality of in vitro fertilization 
(IVF) patients. 
Study design: Non-randomized experimental study (OAT and non-OAT were 
assigned antioxidative supplement treatment, semen quality quality before and 
after treatment). 
Study population: 
The study population were IVF 147 patients. These patients were divided into 
two groups: OAT group (39 men) and Non-OAT group (108 men) based on the 
semen quality according to WHO criteria. 
Recruitment criteria: 
They consented to an antioxidative supplementation. 
Had no or were not planning to have testicular sperm extraction (TESE). 
Did not exhibit indication of azoospermia. 
Did not have genetic reasons for an oligoasthenoteratozoospermia (OAT) 
syndrome. 
Had no chemotherapy or exposure to other noxious agents in the past and did not 
have any other medication with known influence on sperm quality. 
Treatment:
After the first semen analysis all patients were treated with oral Fertilocit, an 
antioxidant supplement containing vitamin C, vitamin E, folic acid, zinc, 
selenium, N-acetyl-L-cysteine, L-carnitine, citrulline, glutathione red., lycopene 
and Coenzyme Q10 for 2 months.
Laboratoty analysis:
Semen parameters such as, volume, concentration, motility, viability and 
morphology were determined on freshly ejaculated semen according to WHO 
guidelines. For motile sperm organelle morphology examination (MSOME)
spermatozoa were classified as grade I: normal shape, size, and no vacuoles or 
only small vacuole(s) (< 4 % of the sperm’s head), Grade II: spermatozoa with 
normal shape and size, but with one or more vacuoles (> 4 % of the sperm’s 
head) and Grade III: abnormal shape and/or size with or without vacuoles, after 
purification of sperm cells by gradient method. Semen parameter data before 
Fertilocit treatment and after treatment were caompared
Statistical analysis: 
Statistical significance differences between groups (sample volume, total motile 
sperm count and MSOME criteria) non-parametric Wilcoxon test was applied. 
OAT group (39 men) revealed lower sperm 
motility, sperm concentration, smaller 
ejaculation volume and lower percentage of 
MSOME Grade I spermatozoa before 
treatment comparing to non-OAT group (108 
men). 
The second semen analysis was performed 2 
to 12 months after an antioxidative 
supplementation. There was significantly 
more progressive motile sperm in the OAT-
group. The total sperm number of the OAT-
group was significantly increased, but not in 
the non-OAT group. OAT-group had 
significantly increased non-linear motility and 
the decreased percentage of immotile sperm. 
In the non-OAT group there was no 
significant increase of progressive motility or 
in total motility. The percentage of Grade I 
spermatozoa according to MSOME criteria 
was significantly higher after antioxidative 
supplementation in the OAT-group. 
In Summary:
After the antioxidative therapy there was 
significant improvement in semen parameter. 
The percentage of class I spermatozoa 
according to MSOME criteria was 
significantly higher after antioxidative
supplementation treatment. 
Are the groups recruited from the same population/section of 
the population? Yes. 
Were the exposed individual representative from the defined 
population/section of the population? Yes, they were typical 
IVF-attenders. 
Were the groups comparable in terms of background factors? 
Yes. 
Was the study prospective? Yes, semen samples were collected 
and analysed after antioxidants treatment. 
Was expositions and outcome measured the same way and 
reliable? Outcome was measured by semen analysis of all 
patients. The time of antioxidant consumption seems however to 
vary greatly and intake of drug/compliance was not controlled by 
blood tests e.g. So maybe this is not reliable. 
Sufficient number of persons followed up?
Yes, 147 men were included. 
Was the follow-up time long enough to detect 
positive/negative outcomes? Yes. 
Are important confounders considered in the study design? 
Yes. 
Is the person who evaluated the results (endpoints) blinded 
group identification? No.
Strengths
• Clear recruitment criteria and group separation
• Relatively a good number of patient included.
• Defined inclusion criteria.  
Limitations
• Great variation of the length of supplement consumption (2-
12 months) and the time of second semen analysis. 
Standardized duration lacking.
• Antioxidant therapy was composed of many different 
substances, which one had effects?
• Higher number of patients are in non-OAT group vs. OAT 
group. 
Does the results have biological explanations? Yes
Does the author refer to other literature that supports or 
contradicts the results? Yes
Conclusion
Antioxidants dietary supplements
improved in semen quality, 
especially for
oligoasthenoteratozoospermia (OAT) 
patients. An antioxidative and 
micronutrient supplementation has 
remarkable benefit for IVF patients 




Year of data sampling
January 2008 – July 2011. 
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Reference: Mendiola J, Torres-Cantero AM, Vioque J, Moreno-Grau JM, Ten J, Roca M, et al. A low intake of antioxidant nutrients is associated 
with poor semen quality in patients attending fertility clinics. Fertility and Sterility. 2010;93(4):1128-33.
Grade
Level 4
Recommendation     C
Aim Materials and methods Results Discussion and comments
To compare specific nutrient intake 
between normospermic and 
oligoasthenoteratospermic patients 
attending infertility clinics in two 
Mediterranean provinces of Spain. 
Study design: Case-control study
Study population: 
A total of 61 men were participated in the study from three 
infertility centers were classified into two groups on the basis 
of seminal quality as: Case (n = 30): men with severe or 
moderate oligozoospermia and severe teratozoospermia and 
Control (n = 31): normospermic patients.  
Laboratory analysis:
Semen parameters such as, volume, concentration, motility, 
viability and morphology were determined on freshly 
ejaculated semen obtained after minimum 3 days of sexual 
abstinence following Krugers strict criteria. Subjects provided 
at least two semen samples. 
Self reported questionnaires on dietary intake:
Study participants were interviewed by the same trained 
fieldworker, who was blinded regarding case-control patient 
status. Structured questionnaires to collect information 
Questionnaire to collect information regarding occupational 
history. A semi-quantitative food frequency questionnaire of 93 
food items was used to assess usual dietary intake. 
Statistics: 
SPSS was used. Results presented as percentage and mean with 
standard deviation (SD). Student T-test was used for means 
comparison of continuous variables, X2-tests were used for 
categoric Variables. Statistical significance was set less than 
0.05 p values and all test were two-tailed. 
• Distribution of age, BMI and hormone levels were similar between 
case and control subjects. 
• Control subjects presented significantly higher intakes of 
carbohydrates, fiber, folate, vitamin C and lycopene and lower 
intakes of proteins and total fat in logistic regression. Control 
subjects had also been exposed less frequent to occupational toxics 
than case subjects. 
Were the case-control groups recruited from 
comparable populations? Yes. 
Are the groups comparable in terms of important 
backgrounds factors? Yes. 
Are the casus groups condition sufficient described? Is 
the diagnose validated? Yes, the cases were diagnosed 
with oligozoosperma and teratozoospermia before 
participation. 
Is the control groups healthy? Yes, normozospermic
patients.  
Are important confounders considered in the 
design/analysis? Yes. Age, tobacco smoking, 
occupational factors e.g. were adjusted for.
Is the exposure for danger/harm/ intervention 
measured and graded equally in the groups? Yes. 
Semen analysis, interviews, questionnaires. 
Was the one who measured the exposure blinded in 
terms of casus/control? Yes. 
Was the response rate sufficient in both groups? Yes.
Strengths




• Significantly differences in terms of diet and 
occupational exposure between cases and controls.   
Weakness
• Small sample number
• Other confounders could be included; medications? 
Alcohol? Exercise? 
Conclusion
A low intake of antioxidant nutrients 
was associated with a poor semen 
quality in a Mediterranean 
population of Spanish men. 
Country
Spain









Aim Materials and methods Results Discussion and comments
To determine whether dietary 
and supplement intake of 
specific micronutrients (zinc and 
folate) and antioxidants (vitamin 
C, E and b-carotene) are 
associated with semen quality. 
Study design: Observational study (cross-sectional)
Study population: 
The study population consisted of 97 healthy male volunteers. Male 
volunteers were recruited from advertisements, e-mail list servers, 
posters and newsletters. Fifteen men from each decade from 20 to 
60 years of age were enrolled, and additionally 25 men from 60 to 
80 years of age were screened over telephone.
Exclusion criteria:
Cigarette smokers, the last 6 months. 
Current fertility or reproductive problems 
Had a vasectomy 
History of prostate cancer or undescended testicles 
Received chemotherapy or radiation for cancer 
Previous semen analysis with zero count
Having a fever >101 oF in the prior 3 months
Twenty men were excluded based on the above criteria.
Laboratory analysis:
Semen parameters such as semen volume, sperm cell concentration, 
total sperm count, motility, progressive motility and total 
progressively motile sperm count TPMS) were determined on 
freshly ejaculated semen obtained after minimum 3 days of sexual 
abstinence following WHO strict criteria. Subjects provided at least 
two semen samples. 
Self reported dietary assessment:
Men were mailed a questionnaire and semen collection container 
with instructions. Questionnaire asked about medical and 
reproductive history, socio-demographic characteristics, 
occupation, lifestyle, and habits and characteristics. Daily intake of 
nutrients were estimated by self-administered modified block food 
frequency questionnaire (FFQ).
Statistical analysis: 
Multivariate regression analysis with covariate selection based on 
the literature
After controlling for covariates, a high intake of antioxidants was 
associated with better semen quality, but in almost all cases there 
was no clear dose relationship in that moderate intake groups had the 
poorest semen quality. 
For example, positive associations were observed between vitamin C 
intake and sperm number as reflected in the higher mean count, 
concentration and TPMS; between vitamin E intake and progressive 
motility and TPMD; and between b-carotene intake and sperm 
concentration and progressive motility. Folate and zinc intake were 
not associated with improved semen quality. 
Is the study population clearly defined? Yes. 
Is the study representative for the general population? 
Yes. 
Is it described how non-responders differ in 
characteristics from responders? No, this is not studied. 
This can be a selection bias issue. 
Is the answer % high enough? Not given. 
Was the data sampling standardized? Yes. 
Are objective criteria used for evaluating the outcome 
measures? Yes, semen quality was evaluated in all 
patients. 




• Wide distribution of age
• General population represented, clear exclusion criteria
• Published in high-impact journal 
Weaknesses 
• Unclear whether analysis of semen was blinded 
concerning results from questionnaire and interview. 
• Simplified investigation of dietary and supplement 
habits. 
• Many potential confounders; physical activity, smoking 
the past, somatic diseases etc. 
Conclusion
In a convenience sample of 
healthy non-smoking men from 
a non-clinical setting, higher 
antioxidant intake was 
associated with higher sperm 
cell number and motility. 
Antioxidant intake may 








Reference: Garcez ME, ds Santos Branco C, Lara LV, Pasqualotto FF, Salvador M. Effects of resveratrol supplementation on cryopreservation 




Aim Materials and methods Results Discussion /comments
To analyse oxidative stress 
markers and seminal standard 
parameters after using 
resveratrol (0.1, 1.0 and 10.0 
mM), an important 
antioxidant, in the 
cryopreservation of human 
semen. 
Study design: Observational study (case-control in vitro perspective study)
Study population:
Subjects: The study group included infertile (20 men) and fertile (10 men) 
subjects. Infertile men were diagnosed after at least two successive semen 
analysis with a partner having no problem. Fertile men were proven fertility
either pregnant partner of delivered a child within the previous 2 years.  
Exclusion criteria: 
Presence of azoospermia, severe oligozoospermia or leukocytospermia, use of 
medications/antioxidants, exposure to chemotherapy or radiation or 
varicoceletomy.  
Laboratory analysis:
Semen parameters such as semen volume, sperm cell concentration, total sperm 
count, motility, progressive motility were determined on freshly ejaculated 
semen obtained after minimum 3 days of sexual abstinence following WHO 
criteria and assessment of morphology by using Krugers criteria. 
Oxidative stress markers 
Levels of thiobarbituric acid-reactive species (TBARS), superoxide dismutase 
(SOD) and catalase (CAT) were assessed,
Cryopreservation with resveratrol 
Semen samples were separated into four aliquots; without resveratrol and with 
0.1, 1.0 and 10.0mM of resveratrol. Thereafter cryopreserved with standard 
procedure.. Post-thawing analysis was after performed 72 hours. Samples were 
removed from liquid nitrogen, thawed in room temperature for 5 minutes and 
incubated at 37 oC for 5-10 minutes. Thereafter washed with medium and then 
evaluated for oxidative and seminal parameters. 
Statistical analysis: 
SPSS, statistical significance  P > 0,05. Mann-Whitney-U.test, Wilcoxons test, 
Spearmans test. 
Infertile men presented with lower sperm concentration, 
motility and morphology when compared with fertile 
men. There was also significant higher average of sperm 
with cryoplasmic droplets among infertile when 
compared with the control group. Infertile men had lower 
SOD and CAT activities and higher levels of lipid 
damages in prefreezing samples compared to fertile men. 
Cryopreservation induced decrease in SOD activity and 
increase in CAT activity and TBARS levels in infertile 
men.  
Fertile men had no alteration in SOD activity after 
cryopreservation, however increase in CAT activity in 
post-thawing samples. Increase in lipid damages after 
cryopreservation. 
Addition of resveratrol (0.1, 1.0 and 10.0 mM) was able 
to prevent lipid damages induced by cryopreservation in 
both fertile and infertile men. The effect was not dose-
dependent. 
In fertile men, the addition of resveratrol did not change 
SOD and CAT activities. In infertile, an increase in SOD 
activity was observed. 
The cryopreservation process was not able to change 
sperm concentration or motility. A decrease in sperm 
motility was observed in both fertile and infertile men. 
Were the case-control groups recruited from 
comparable populations? Yes, samples were collected 
from patients in one clinic. Fertile and infertile male were 
recruited. 
Are the groups comparable in terms of important 
background factors? Yes.
Are the casus groups condition sufficiently described? Is 
the diagnose validated? Yes, they are sufficiently 
described. Infertile men were diagnosed after at least two 
semen analysis. 
Is the control groups healthy? Yes. 
Are important confounders considered in the 
design/analysis? Yes, defined exclusion/inclusion criteria 
helps reducing the risk of confounders. 
Is the exposure for danger/harm/ intervention measured 
and graded equally in the groups? Yes, the same 
laboratory techniques were used. 
Was the one who measured the exposure blinded in 
terms of casus/control? No.
Was the responsrate sufficient in both groups? Yes. 
Strengths
• Defined inclusion/exclusion criteria
• Standardized methods used
• Long enough follow-up time to detect outcomes. 
Limitations
• Small sample 
• Unequal distribution of patients in the two groups 
Conclusion
Resveratrol avoids oxidative 
damages induced by the 
cryopreservation of human 
semen, but it it not able to 




Year of data sampling
2010 
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Appendix 1: Consent form  
 
Samtykkeskjema for bruk av sædprøve til andre formål enn 
pasientbehandling 
 
Forskningsstudien: Oksidativt stress og sæd kvalitet 
 
Avdeling: Kvinnehelse og perinatologi forskjæring gruppe i Universitetet i 
Tromsø 
 
Ansvarlig person/Prosjektleder: Professor Purusotam Basnet 
 
Formål med bruk av prøven: 
Denne forskningsstudien blir gjennomført av Med. Stud/PhD under veiledning 
av Prof. Purusotam Basnet for å undersøke sammenhenger mellom sædkvalitet 
og oksidativt stress. 
 
Bevegelsen av sædceller vil være studier under ulike oksidative stress og 
antioksidanter, og endringer i mitokondriet vil bli observert. 
 
Konfidensialitet 
Alle prøver og data vil bli anonymisert nor vi mottar prøven. Det er derfor ikke i 
ettertid ikke mulig å spore giver eller knytte resultater opp mot person. 
Forsøksdeltakere vil ikke bli utsatt for noe risiko. Prøvene vil bare bli brukt til 







Signatur prosjektleder    Signatur pasient 
Dato:       Dato: 
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Appendix 2: Rettledning for levering av sædprøve ved 
Fertilitetspoliklinikken UNN 
 
